First person – Jelmer Hoeksma

Abstract

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jelmer Hoeksma is first author on ‘Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish’, published in DMM. Jelmer is a PhD student/technician in the lab of Jeroen den Hertog at Hubrecht Institute, Utrecht, The Netherlands, identifying biologically active fungal compounds and uncovering their mode of action in vivo.